Skip to content
Home/Companies/MedTech/Bridge to Life

Bridge to Life

MedTech·United States·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Bridge to Life?

Bridge to Life is an American MedTech company, currently owned by Lauxera Capital Partners since 2026.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Lauxera Capital Partners
Investor
Lauxera Capital Partners
Lauxera Growth II · 2025 · Growth

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Lauxera Growth II

Other portfolio companies in the same fund.

GenePlanet
Active
BiotechSlovenia· 2026
Antaros Medical
Antaros Medical
Active
BiotechSweden· 2025
Acandis
Acandis
Active
MedTechGermany· 2024

More Lauxera Capital Partners portfolio companies

From the same investor, across funds.

Natural Cycles
Natural Cycles
Active
HealthTechSweden· 2024
Ospi
Ospi
Active
HealthTechFrance· 2024
BioLamina
BioLamina
Active
BiotechSweden· 2023
Caresyntax
Active
HealthTechGermany· 2023
Matrix One
Matrix One
Active
HealthTechGermany· 2023
Reapplix
Reapplix
Active
MedTechDenmark· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Bridge to Life?

Bridge to Life is currently owned by Lauxera Capital Partners, through Lauxera Growth II, since 2026.

When did Lauxera Capital Partners acquire Bridge to Life?

Lauxera Capital Partners acquired Bridge to Life in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue